Bahirwani R, Reddy KR. Review article: the evaluation of solitary liver masses. Aliment Pharmacol Ther. 2008;28(8):953–65.

CAS  PubMed  Google Scholar 

Brouwers MA, Peeters PM, de Jong KP, Haagsma EB, Klompmaker IJ, Bijleveld CM, et al. Surgical treatment of giant haemangioma of the liver. Br J Surg. 1997;84(3):314–6.

CAS  PubMed  Google Scholar 

Leon M, Chavez L, Surani S. Hepatic hemangioma: what internists need to know. World J Gastroenterol. 2020;26(1):11–20.

CAS  PubMed  PubMed Central  Google Scholar 

Tait N, Richardson AJ, Muguti G, Little JM. Hepatic cavernous haemangioma: a 10 year review. Aust N Z J Surg. 1992;62(7):521–4.

CAS  PubMed  Google Scholar 

Aziz H, Brown ZJ, Baghdadi A, Kamel IR, Pawlik TM. A comprehensive review of hepatic hemangioma management. J Gastrointest Surg. 2022;26(9):1998–2007.

PubMed  Google Scholar 

Bioulac-Sage P, Laumonier H, Laurent C, Blanc JF, Balabaud C. Benign and malignant vascular tumors of the liver in adults. Semin Liver Dis. 2008;28(3):302–14.

PubMed  Google Scholar 

Sakamoto Y, Kokudo N, Watadani T, Shibahara J, Yamamoto M, Yamaue H. Proposal of size-based surgical indication criteria for liver hemangioma based on a nationwide survey in Japan. J Hepatobiliary Pancreat Sci. 2017;24(7):417–25.

PubMed  Google Scholar 

Herman P, Costa ML, Machado MA, Pugliese V, D’Albuquerque LA, Machado MC, et al. Management of hepatic hemangiomas: a 14-year experience. J Gastrointest Surg. 2005;9(6):853–9.

PubMed  Google Scholar 

Zhang W, Huang ZY, Ke CS, Wu C, Zhang ZW, Zhang BX, et al. surgical treatment of giant liver hemangioma larger than 10 cm: a single center’s experience with 86 patients. Medicine (Baltimore). 2015;94(34):e1420.

PubMed  Google Scholar 

Behar A, Moran E, Izak G. Acquired hypofibrinogenemia associated with a giant cavernous hemangioma of the liver. Am J Clin Pathol. 1963;40:78–82.

CAS  PubMed  Google Scholar 

Miura JT, Amini A, Schmocker R, Nichols S, Sukato D, Winslow ER, et al. Surgical management of hepatic hemangiomas: a multi-institutional experience. HPB (Oxford). 2014;16(10):924–8.

PubMed  Google Scholar 

Liu X, Yang Z, Tan H, Xu L, Sun Y, Si S, et al. Giant liver hemangioma with adult Kasabach-Merritt syndrome: case report and literature review. Medicine (Baltimore). 2017;96(31):e7688.

PubMed  Google Scholar 

Hoekstra LT, Bieze M, Erdogan D, Roelofs JJ, Beuers UH, van Gulik TM. Management of giant liver hemangiomas: an update. Expert Rev Gastroenterol Hepatol. 2013;7(3):263–8.

CAS  PubMed  Google Scholar 

Pulvirenti E, Toro A, Di Carlo I. An update on indications for treatment of solid hepatic neoplasms in noncirrhotic liver. Future Oncol. 2010;6(8):1243–50.

PubMed  Google Scholar 

Qiu J, Chen S, Wu H. Quality of life can be improved by surgical management of giant hepatic haemangioma with enucleation as the preferred option. HPB (Oxford). 2015;17(6):490–4.

PubMed  Google Scholar 

Cheng WL, Qi YQ, Wang B, Tian L, Huang W, Chen Y. Enucleation versus hepatectomy for giant hepatic haemangiomas: a meta-analysis. Ann R Coll Surg Engl. 2017;99(3):237–41.

CAS  PubMed  Google Scholar 

Zheng N, Ding X, Jahan R. Low concentration of rapamycin inhibits hemangioma endothelial cell proliferation, migration, and vascular tumor formation in mice. Curr Ther Res Clin Exp. 2014;76:99–103.

CAS  PubMed  PubMed Central  Google Scholar 

Vignot S, Faivre S, Aguirre D, Raymond E. mTOR-targeted therapy of cancer with rapamycin derivatives. Ann Oncol. 2005;16(4):525–37.

CAS  PubMed  Google Scholar 

Seront E, Van Damme A, Legrand C, Bisdorff-Bresson A, Orcel P, Funck-Brentano T, et al. Preliminary results of the European multicentric phase III trial regarding sirolimus in slow-flow vascular malformations. JCI Insight. 2023;8(21):e173095.

PubMed  PubMed Central  Google Scholar 

Boon LM, Ballieux F, Vikkula M. Pathogenesis of vascular anomalies. Clin Plast Surg. 2011;38(1):7–19.

PubMed  PubMed Central  Google Scholar 

ISSVA Classification of Vascular Anomalies ©2025 International Society for the Study of Vascular Anomalies Available at "issva.org/classification". Available from: https://www.issva.org/classification. Accessed 30 Apr 2025.

Lekwuttikarn R, Josephs S, Teng JM. Successful medical management of life-threatening hepatic hemangioma in neonates. Pediatrics. 2019;144(4):e20191339.

PubMed  Google Scholar 

Moon SJ, Baek HJ, Kim BR, Park WJ, Kim J, Lee YY, et al. Successful management of massive congenital hepatic hemangioma and systemic hypertension with sirolimus. J Pediatr Hematol Oncol. 2022;44(2):e424–7.

CAS  PubMed  Google Scholar 

Warren D, Diaz L, Levy M. Diffuse hepatic hemangiomas successfully treated using sirolimus and high-dose propranolol. Pediatr Dermatol. 2017;34(5):e286–7.

PubMed  Google Scholar 

Lee S, Jeon H, Han J, Song IK, Baek SH, Shim S, et al. Management of neonatal hepatic hemangiomas: a single-center experience focused on challenging cases. J Clin Med. 2024;13(10):2839.

CAS  PubMed  PubMed Central  Google Scholar 

Cîrstoveanu C, Bizubac AM, Mustea C, Manolache Ș, Istrate-Bârzan A, Sfrijan D, et al. Antiproliferative therapy with sirolimus and propranolol for congenital vascular anomalies in newborns (Case reports). Exp Ther Med. 2021;22(4):1097.

PubMed  PubMed Central  Google Scholar 

Kacała A, Dorochowicz M, Matus I, Puła M, Korbecki A, Sobański M, et al. Hepatic hemangioma: review of imaging and therapeutic strategies. Medicina (Kaunas). 2024;60(3):449.

PubMed  Google Scholar 

Mungovan JA, Cronan JJ, Vacarro J. Hepatic cavernous hemangiomas: lack of enlargement over time. Radiology. 1994;191(1):111–3.

CAS  PubMed  Google Scholar 

Glinkova V, Shevah O, Boaz M, Levine A, Shirin H. Hepatic haemangiomas: possible association with female sex hormones. Gut. 2004;53(9):1352–5.

CAS  PubMed  PubMed Central  Google Scholar 

Abdel Wahab M, El Nakeeb A, Ali MA, Mahdy Y, Shehta A, Abdulrazek M, et al. Surgical management of giant hepatic hemangioma: single center’s experience with 144 patients. J Gastrointest Surg. 2018;22(5):849–58.

PubMed  Google Scholar 

Xie QS, Chen ZX, Zhao YJ, Gu H, Geng XP, Liu FB. Outcomes of surgery for giant hepatic hemangioma. BMC Surg. 2021;21(1):186.

PubMed  PubMed Central  Google Scholar 

Torkian P, Li J, Kaufman JA, Jahangiri Y. Effectiveness of transarterial embolization in treatment of symptomatic hepatic hemangiomas: systematic review and meta-analysis. Cardiovasc Intervent Radiol. 2021;44(1):80–91.

PubMed  Google Scholar 

Ho HY, Wu TH, Yu MC, Lee WC, Chao TC, Chen MF. Surgical management of giant hepatic hemangiomas: complications and review of the literature. Chang Gung Med J. 2012;35(1):70–8.

PubMed  Google Scholar 

Özden İ, Poyanlı A, Önal Y, Demir AA, Hoş G, Acunaş B. Superselective transarterial chemoembolization as an alternative to surgery in symptomatic/enlarging liver hemangiomas. World J Surg. 2017;41(11):2796–803.

PubMed  Google Scholar 

Li Y, Jia Y, Li S, Wang W, Wang Z, Wang Y, et al. Transarterial chemoembolization of giant liver haemangioma: a multi-center study with 836 cases. Cell Biochem Biophys. 2015;73(2):469–72.

CAS  PubMed  Google Scholar 

Kacała A, Dorochowicz M, Korbecki A, Sobański M, Puła M, Patrzałek D, et al. Transarterial bleomycin-lipiodol chemoembolization for the treatment of giant hepatic hemangiomas: an assessment of effectiveness. Cancers (Basel). 2024;16(2):380.

PubMed  Google Scholar 

Kong J, Gao R, Wu S, Shi Y, Yin T, Guo S, et al. Safety and efficacy of microwave versus radiofrequency ablation for large hepatic hemangioma: a multicenter retrospective study with propensity score matching. Eur Radiol. 2022;32(5):3309–18.

PubMed  Google Scholar 

Wen SQ, Wan M, Len KM, Hu QH, Xie XY, Wu Q, et al. Safety and efficacy of laparoscopic radiofrequency ablation for hepatic hemangiomas: a multicenter retrospective study. Ann Hepatol. 2018;17(2):268–73.

PubMed  Google Scholar 

Wang Z, Tang X, Qi X, Shi Y, Chi J, Li P, et al. Feasibility, safety, and efficacy of ultrasound-guided percutaneous microwave ablation for giant hepatic hemangioma. Int J Hyperthermia. 2018;35(1):246–52.

PubMed  Google Scholar 

Shi Y, Song J, Ding M, Tang X, Wang Z, Chi J, et al. Microwave ablation versus transcatheter arterial embolization for large hepatic hemangiomas: clinical outcomes. Int J Hyperthermia. 2020;37(1):938–43.

PubMed  Google Scholar 

Tang X, Ding M, Lu B, Chi J, Wang T, Shi Y, et al. Outcomes of ultrasound-guided percutaneous microwave ablation versus surgical resection for symptomatic large hepatic hemangiomas. Int J Hyperthermia. 2019;36(1):632–9.

PubMed  Google Scholar